Are you a student, new practitioner, or professional considering a transition into managed care pharmacy? Join AMCP on Wednesday, Sept. 24, at 7:00 pm ET for an engaging webinar that will introduce you to the foundations of managed care pharmacy, the diverse roles available, and the real-world impact managed care pharmacists have on patients, health plans, and the health care system.

This session is designed for those exploring career options, looking to expand their professional opportunities, or seeking a better work-life balance in a growing field. You'll learn how managed care pharmacists shape formularies, influence evidence-based coverage decisions, improve medication access, and drive value-based care - all while keeping patients at the center. Whether you're just beginning your career or considering a new direction, this program will provide insights to help you envision your future in managed care pharmacy.

Faculty – Members of the AMCP Membership Committee: 

Kenneth Garcia, PharmD 
Regional Account Director, Sanofi 

Vi Huynh, PharmD, MPH, MS
Senior Manager, Public Policy, Centene Corporation

Tanya Kuzminsky  
Regional Payer Account Director, Lundbeck 

Alina Liang, PharmD 
Clinical Pharmacist Project Director, Prime Therapeutics 

Greg Shelton 
National Account Director, Payer Access; Regeneron 

Explore the evolving dynamics of H.R. 1 on the individual marketplace and the implications for health plans and PBMs. Key topics include H.R. 1’s changes in marketplace and premium tax credit eligibility; the pending expiration of enhanced premium tax credits; and the resulting impact on coverage options, risk pools, and benefit design. Faculty will touch on the interplay between Medicaid expansion and marketplace trends, especially where eligibility overlaps or diverges. Additionally, ongoing litigation surrounding marketplace rules will be examined, including recent court decisions and unresolved regulatory questions.

Reliable drug information is the backbone of safe and effective patient care. It's what helps make informed decisions, optimize therapeutic outcomes, and confidently navigate the complex healthcare landscape. For early-career professionals, knowing where to find trusted, evidence-based resources - like drug databases and clinical decision-support tools - can be a real game-changer.

Crohn's disease and ulcerative colitis are chronic autoimmune disorders associated with major clinical and economic burden. The American College of Gastroenterology (ACG) recently released updates to their clinical guidelines for the Management of Crohn's Disease (CD) and Ulcerative Colitis (UC) in Adults. Both guidelines incorporate available evidence to provide recommendations for the treatment and prevention of complications associated with inflammatory bowel disease (IBD). The objective of this webinar is to highlight guideline updates and provide suggestions for application of the recommendations into practice and payer policy.

IgA nephropathy is an autoimmune, progressive, chronic kidney disease characterized by pathogenic IgA accumulation and immune complex formation in the glomerulus, causing inflammation and progressive kidney damage. The webinar will review IgA nephropathy and clinical outcomes from Phase 2 and 3 trials of an investigational product that is under clinical evaluation for the treatment of primary IgA nephropathy in adults. Efficacy and safety have not yet been established.

Advance understanding of the importance of frequent monitoring risk level of pulmonary arterial hypertension (PAH) and right heart monitoring. Explore and discuss the importance of timely escalation of therapies in the treatment of PAH. Participants will learn about the significant role risk stratification plays in informing providers' treatment decisions, as well as the importance of right heart and hemodynamic considerations in conjunction with risk assessment.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

This webinar highlights an introduction to Scholar Rock, an emerging biopharmaceutical company, and provides an overview of the Spinal Muscular Atrophy (SMA) disease landscape, remaining unmet needs in SMA, and apitegromab clinical data.